AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 30136707
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate nasal spray at 200 microgram once daily for 3 months
Trial: 26391671
Drug: Clomiphene citrate
RxNorm normalized name: Clomiphene Citrate
DrugBank: Clomifene (DB00882)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clomiphene citrate (CC) + low-dose ethinyl estradiol (EE) (0.05 mg daily for 5 days)
Trial: 26391671
Drug: Clomiphene citrate
RxNorm normalized name: Clomiphene Citrate
DrugBank: Clomifene (DB00882)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clomiphene citrate (CC) + placebo
Trial: 8977237
Drug: Granulocyte colony-stimulating
RxNorm normalized name: Granulocyte colony-stimulating factor lenograstim
DrugBank: Lenograstim (DB13144)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granulocyte colony-stimulating factor (G-CSF) plus stem cell factor (SCF)
Trial: 6135507
Drug: Amobarbital sodium
RxNorm normalized name: Amobarbital Sodium
DrugBank: Amobarbital (DB01351)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amobarbital sodium (100 mg)
Trial: 11738299
Drug: Aspirin (ASA)
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin (ASA) nonusers
Trial: 9793614
Drug: Rectal administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rectal administration of tramadol suppositories (100 mg)
Trial: 2422461
Drug: Intravenous digoxin
RxNorm normalized name: Digoxin
DrugBank: Digoxin (DB00390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous digoxin (definite infarction subgroup)
Trial: 8382969
Drug: Interferon-alpha (IFN-alpha)
RxNorm normalized name: Interferon alpha-2B
DrugBank: Interferon alfa-2b (DB00105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interferon-alpha (IFN-alpha) therapy (2 x 10(6) IU daily for a month, then every other day for 5 months)
Trial: 8610733
Drug: Interferon-alpha (IFN-alpha)
RxNorm normalized name: Interferon alpha-2B
DrugBank: Interferon alfa-2b (DB00105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interferon-alpha (IFN-alpha) therapy
Trial: 22721608
Drug: Estradiol gel
RxNorm normalized name: ESTRADIOL 1 mg in 1 g TOPICAL GEL [Estradiol Gel]
DrugBank: Estradiol acetate (DB13952)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Estradiol gel (2mg)
Trial: 801352
Drug: Low-dose heparin
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose heparin (LDH)
Trial: 6925576
Drug: Cimetidine (oral)
RxNorm normalized name: Cimetidine
DrugBank: Cimetidine (DB00501)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cimetidine (oral)
Trial: 25295804
Drug: C1 inhibitor
RxNorm normalized name: C1 INHIBITOR
DrugBank: Conestat alfa (DB09228)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: C1 inhibitor (C1 INH‐nf; human) 1000 U intravenous injections every 3-4 days for 12 weeks
Trial: 22145448
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human growth hormone (rhGH)
Trial: 31840388
Drug: Post-treatment sun
RxNorm normalized name: hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Post-treatment sun protection
Trial: 14567499
Drug: L-type Ca
RxNorm normalized name: VOLTAGE-DEPENDENT L-TYPE CALCIUM CHANNEL SUBUNIT ALPHA-1C
DrugBank: MEM 1003 (DB05547)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-type Ca channel blocker (nifedipine CR)
Trial: 10423075
Drug: Active treatment
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatment (nitrendipine, with possible addition of enalapril and hydrochlorothiazide)
Trial: 17558827
Drug: Medication compliance
RxNorm normalized name: ribavirin
DrugBank: Ribavirin (DB00811)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Medication compliance
Trial: 16923452
Drug: Colesevelam HCl
RxNorm normalized name: colesevelam HCl
DrugBank: Colesevelam (DB00930)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Colesevelam HCl (3.75 g/day for 6 weeks)
Trial: 30767047
Drug: Streptococcus salivarius
RxNorm normalized name: Streptococcus salivarius
DrugBank: Streptococcus salivarius (DB19274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Streptococcus salivarius 24SMB and Streptococcus oralis 89a oral spray
Trial: 28939004
Drug: Prednisone 10mg
RxNorm normalized name: PREDNISONE 10MG TAB
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prednisone 10mg daily
Trial: 17446716
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of lutein
Trial: 27893045
Drug: Chlorthalidone vs
RxNorm normalized name: Chlorthalidone
DrugBank: Chlorthalidone (DB00310)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorthalidone vs Lisinopril
Trial: 11740759
Drug: Adjusted low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Adjusted low-dose warfarin (INR 1.4-1.8)
Trial: 17627241
Drug: Conventional CsA
RxNorm normalized name: CsA
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional CsA triple therapy without induction
Trial: 23585997
Drug: Adjunctive aripiprazole
RxNorm normalized name: Aripiprazole
DrugBank: Aripiprazole (DB01238)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Adjunctive aripiprazole
Trial: 22695489
Drug: Almorexant 400
RxNorm normalized name: Nemorexant
DrugBank: Daridorexant (DB15031)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Almorexant 400 mg
Trial: 6357901
Drug: Xenon-arc photocoagulation
RxNorm normalized name: xenon
DrugBank: Xenon (DB13453)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xenon-arc photocoagulation treatment in one eye
Trial: 1507019
Drug: Therapies evaluated
RxNorm normalized name: Theraplex Eczema Therapy
DrugBank: Colloidal oatmeal (DB11286)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapies evaluated based on actual clinical changes rather than presumed etiologic factors.
Trial: 18515447
Drug: THC 8
RxNorm normalized name: THC
DrugBank: Dronabinol (DB00470)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: THC 8 mg
Trial: 30185793
Drug: THC 8
RxNorm normalized name: THC
DrugBank: Dronabinol (DB00470)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: THC 8 mg + CBD 16 mg
Trial: 26333723
Drug: Intra-aortic balloon
RxNorm normalized name: somatropin
DrugBank: Somatotropin (DB00052)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intra-aortic balloon pump (IABP) treatment
Trial: 10952480
Drug: Methylene blue
RxNorm normalized name: Methylene Blue
DrugBank: Methylene blue (DB09241)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylene blue with mesna (100 mg)
Trial: 17332177
Drug: Varicella vaccine
RxNorm normalized name: Varicella vaccine
DrugBank: Varicella zoster vaccine (live/attenuated) (DB10318)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Varicella vaccine
Trial: 20399899
Drug: Chondroitin sulphate
RxNorm normalized name: Chondroitin sulphate
DrugBank: Chondroitin sulfate (DB09301)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chondroitin sulphate (CS) 800 mg daily for 3 months
Trial: 29572284
Drug: IV aminophylline
RxNorm normalized name: Aminophylline
DrugBank: Aminophylline (DB01223)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV aminophylline 250 mg
Trial: 8334029
Drug: Calcium carbonate
RxNorm normalized name: Calcium Carbonate
DrugBank: Calcium carbonate (DB06724)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium carbonate (maximal dosage of 1 g x 3)
Trial: 12368690
Drug: Methylprednisolone 30
RxNorm normalized name: Methylprednisolone
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methylprednisolone 30 mg/kg/dose x3
Trial: 28220020
Drug: ICR +
RxNorm normalized name: Icrucumab
DrugBank: Icrucumab (DB14824)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ICR + CAP (12 mg/kg IV, days 1 and 8; 1,000 mg/m2 orally twice daily, days 1-14)
Trial: 27125345
Drug: RIX4414 vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RIX4414 vaccine
Trial: 14767020
Drug: Beta 2-agonist
RxNorm normalized name: 2-HYDROXYPROPYL-BETA-CYCLODEXTRIN
DrugBank: Hydroxypropyl betadex (DB15379)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta 2-agonist (salbutamol)
Trial: 16231342
Drug: Mirror Exposure
RxNorm normalized name: Bacillus anthracis strain V770-NP1-R antigens
DrugBank: Anthrax vaccine (DB11003)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mirror Exposure (ME) therapy
Trial: 18806065
Drug: Automated bolus
RxNorm normalized name: Peumus boldus leaf extract
DrugBank: Boldo leaf extract (DB15815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Automated bolus doses of 5 mL every hour of 0.125% levobupivacaine for 24 h
Trial: 3375787
Drug: Lyophilized vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lyophilized vaccine reconstituted in a buffer solution
Trial: 3375787
Drug: Initially marketed
RxNorm normalized name: brigatinib
DrugBank: Brigatinib (DB12267)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Initially marketed formulation (2 bicarbonate capsules + vaccine capsule)
Trial: 11144399
Drug: Cefdinir 14
RxNorm normalized name: Cefdinir
DrugBank: Cefdinir (DB00535)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefdinir 14 mg/kg once-daily
Trial: 11259933
Drug: Topically applied
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topically applied medicine (Control group B)
Trial: 26324250
Drug: Nicotine concentration
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicotine concentration of 0 mg/mL
Trial: 1172599
Drug: digoxin tablets
RxNorm normalized name: Digoxin Tablets
DrugBank: Digoxin (DB00390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: digoxin tablets (Digacin¿)
Trial: 6089652
Drug: Intranasal human
RxNorm normalized name: Insulin Human
DrugBank: Insulin human (DB00030)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intranasal human interferon-alpha 2 (HuIFN-alpha 2)
Trial: 17545139
Drug: Video intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Video intervention (set of 10 videos, workbook, weekly telephone coaching sessions)
Trial: 19621690
Drug: 6 g
RxNorm normalized name: FAPi-46 GA-68
DrugBank: FAPi-46 GA-68 (DB18827)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 g AzOAB: Azithromycin 500 mg twice daily for 6 days and Omeprazole 20 mg, Amoxicillin 1 g, Bismuth 240 mg all twice daily for 2 weeks
Trial: 11863118
Drug: Oral etoposide
RxNorm normalized name: Etoposide
DrugBank: Etoposide (DB00773)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral etoposide
Trial: 21765273
Drug: bimanual intensive
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: bimanual intensive rehabilitation treatment (IRP)
Trial: 12807340
Drug: Hypericum cream
RxNorm normalized name: Hypericum oil
DrugBank: St. John's Wort (DB01323)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypericum cream (1.5% hyperforin)
Trial: 31830835
Drug: Peri-conceptional progesterone
RxNorm normalized name: Progesterone
DrugBank: Progesterone (DB00396)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Peri-conceptional progesterone treatment
Trial: 1543140
Drug: Sustained-release diltiazem
RxNorm normalized name: diltiazem
DrugBank: Diltiazem (DB00343)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sustained-release diltiazem (180 mg twice daily)
Trial: 1709020
Drug: Terfenadine tablet
RxNorm normalized name: terfenadine Oral Tablet
DrugBank: Terfenadine (DB00342)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Terfenadine tablet 60 mg twice/day
Trial: 6351889
Drug: Inhaled reproterol
RxNorm normalized name: reproterol
DrugBank: Reproterol (DB12846)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled reproterol (1 mg)
Trial: 11562580
Drug: Uncoated extracorporeal
RxNorm normalized name: nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Uncoated extracorporeal circulation with full dose systemic heparinization (Group A)
Trial: 26283139
Drug: Low-dose intravenous
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose intravenous alteplase (0.6 mg/kg body weight)
Trial: 25115901
Drug: Vaniprevir 600
RxNorm normalized name: Vaniprévir
DrugBank: Vaniprevir (DB11929)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Vaniprevir 600 mg plus PR
Trial: 29771966
Drug: Sodium bicarbonate
RxNorm normalized name: Sodium Bicarbonate
DrugBank: Sodium bicarbonate (DB01390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium bicarbonate (SB) ingestion up to 150 mg∙kg‐1 in a progressive-dose regimen for 10 days
Trial: 16603964
Drug: L-NMMA effect
RxNorm normalized name: L-NMMA
DrugBank: Tilarginine (DB11815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-NMMA effect on RCF
Trial: 25163547
Drug: Biological mesh
RxNorm normalized name: beremagene geperpavec
DrugBank: Beremagene geperpavec (DB17831)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biological mesh closure of the pelvic floor after eAPR
Trial: 16319785
Drug: Iyengar yoga
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Iyengar yoga classes (2 weekly 90-min sessions for 3 months)
Trial: 12920661
Drug: Ultratard insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ultratard insulin
Trial: 3293255
Drug: Chloroquine phosphate
RxNorm normalized name: Chloroquine Phosphate
DrugBank: Chloroquine (DB00608)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chloroquine phosphate and ibuprofen
Trial: 26711799
Drug: Prolonged 60-second
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prolonged 60-second delay for VT therapy ≥170 (Treatment arm C)
Trial: 3512394
Drug: Porcine insulin
RxNorm normalized name: Porcine insulin
DrugBank: Insulin pork (DB00071)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Porcine insulin
Trial: 10581593
Drug: Insulin clamp
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin clamp alone (control)
Trial: 24267730
Drug: Exemestane (EXE)
RxNorm normalized name: Exemestane
DrugBank: Exemestane (DB00990)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Exemestane (EXE) 25 mg/d
Trial: 31105703
Drug: Golimumab (GM)
RxNorm normalized name: Golimumab
DrugBank: Golimumab (DB06674)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Golimumab (GM) treatment
Trial: 24648506
Drug: Amoxicillin thrice
RxNorm normalized name: Amoxicillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amoxicillin thrice daily (50 mg/kg/day)
Trial: 20512273
Drug: Intravenous fentanyl
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous fentanyl (100 microg)
Trial: 26783268
Drug: Carbon nanoparticle
RxNorm normalized name: Calcium Carbonate
DrugBank: Calcium carbonate (DB06724)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Carbon nanoparticle suspension (CNPS)
Trial: 12925476
Drug: Intrathecal diamorphine
RxNorm normalized name: Diamorphine
DrugBank: Diamorphine (DB01452)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal diamorphine (all doses)
Trial: 25779750
Drug: Both apremilast
RxNorm normalized name: Apremilast
DrugBank: Apremilast (DB05676)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Both apremilast doses
Trial: 8646873
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate ointment, 0.005%
Trial: 8635374
Drug: Mitomycin therapy
RxNorm normalized name: Mitomycin
DrugBank: Mitomycin (DB00305)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mitomycin therapy
Trial: 19631949
Drug: Pregabalin (PGB)
RxNorm normalized name: Pregabalin
DrugBank: Pregabalin (DB00230)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Pregabalin (PGB) 150-600 mg/day
Trial: 9602222
Drug: Alcoholic solution
RxNorm normalized name: Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alcoholic solution under occlusion
Trial: 20637971
Drug: Linagliptin single
RxNorm normalized name: Linagliptin
DrugBank: Linagliptin (DB08882)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Linagliptin single doses (1, 2.5, 5, 10 mg)
Trial: 20637971
Drug: Linagliptin multiple
RxNorm normalized name: Linagliptin
DrugBank: Linagliptin (DB08882)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Linagliptin multiple doses (2.5, 5, 10 mg)
Trial: 15834325
Drug: In Clinic
RxNorm normalized name: Stopain Clinical
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: In Clinic Exercise Group (nonelastic sacroiliac belt, oral/written information, and participation in a training program)
Trial: 24816936
Drug: Low-dose unenhanced
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose unenhanced ungated chest CT for AVC measurement
Trial: 24816936
Drug: Low-dose unenhanced
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose unenhanced ungated chest CT for MC measurement
Trial: 15023462
Drug: Commercial reference
RxNorm normalized name: iodine
DrugBank: Iodine (DB05382)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Commercial reference tablet
Trial: 30341175
Drug: Pharmacy intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pharmacy intervention (pharmacist visit during second or third chemotherapy infusion)
Trial: 2646469
Drug: Intensified insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensified insulin therapy (IIT)
Trial: 7839898
Drug: Cytosine arabinoside
RxNorm normalized name: Cytosine arabinoside
DrugBank: Cytarabine (DB00987)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Cytosine arabinoside 100 mg/m2 subcutaneously (sc) 12 hourly for days 1‐5
Trial: 21419776
Drug: Canary pox
RxNorm normalized name: canary feather extract
DrugBank: Serinus canaria feather (DB10857)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Canary pox recombinant vaccine
Trial: 31874865
Drug: Usual practice
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual practice (restrictive diet, physical activity, and thermal spa treatment)
Trial: 1300518
Drug: Discolored lenses
RxNorm normalized name: Salix discolor pollen
DrugBank: Salix discolor pollen (DB10753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Discolored lenses (amber lens discoloration achieved using human‐worn 55% water hydrophilic contact lenses heated in a 1% potassium sorbate, low pH saline solution)
Trial: 25033643
Drug: Psychological nursing
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Psychological nursing intervention and analgesic drug treatment
Trial: 16420547
Drug: Levofloxacin combined
RxNorm normalized name: Levofloxacin
DrugBank: Levofloxacin (DB01137)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Levofloxacin combined with standard treatment
Trial: 1492848
Drug: Flupirtine maleate
RxNorm normalized name: flupirtine maleate
DrugBank: Flupirtine (DB06623)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flupirtine maleate 200 mg
Trial: 31761933
Drug: Empiric TB
RxNorm normalized name: dextroamphetamine
DrugBank: Dextroamphetamine (DB01576)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Empiric TB treatment
Trial: 10738097
Drug: CVD 103-HgR
RxNorm normalized name: Vibrio cholerae CVD 103-hgr strain live antigen
DrugBank: Vibrio cholerae CVD 103-HgR strain live antigen (DB14443)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CVD 103-HgR live oral cholera vaccine
Trial: 12876635
Drug: Transdermal estradiol-1beta
RxNorm normalized name: Estradiol Transdermal System
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal estradiol-1beta combined with micronised progesterone (n=68)
Trial: 21595543
Drug: Traditional Japanese
RxNorm normalized name: Japanese encephalitis virus
DrugBank: Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) (DB10769)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional Japanese massage therapy
Trial: 23679091
Drug: Sodium chloride
RxNorm normalized name: Sodium Chloride
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium chloride (NaCl) 0.045 g/kg body mass
Trial: 17413099
Drug: Higher-protein (HP)
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher-protein (HP) group; 1.2 g protein . kg(‐1) . d(‐1)
Trial: 12875611
Drug: Levocarnitine 2g
RxNorm normalized name: Levocarnitine
DrugBank: Levocarnitine (DB00583)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Levocarnitine 2g twice daily
Trial: 8517932
Drug: Phenobarbital treatment
RxNorm normalized name: Phenobarbital
DrugBank: Phenobarbital (DB01174)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenobarbital treatment
Trial: 22331756
Drug: Cefdinir granule
RxNorm normalized name: Cefdinir
DrugBank: Cefdinir (DB00535)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefdinir granule (test) 100 mg